U.S. Renal Care NNN Investor Hub | Cap Rate Trends, Credit Rating Trends, Lease Terms & Due Diligence

U.S. Renal Care

Last Year Cap

7.2%

This Year Cap

7.5%

Cap Change

0.3%

U.S. Renal Care – NNN Cap Rate Trend

Cap Rate Trends

wdt_ID wdt_created_by wdt_created_at wdt_last_edited_by wdt_last_edited_at Tenant Year Cap Rate
5779 admin2 2026 04:17 AM admin2 2026 04:17 AM 7 Brew 2,020 6.5
5780 admin2 2026 04:17 AM admin2 2026 04:17 AM 7 Brew 2,021 6.3
5781 admin2 2026 04:17 AM admin2 2026 04:17 AM 7 Brew 2,022 6.0
5782 admin2 2026 04:17 AM admin2 2026 04:17 AM 7 Brew 2,023 6.3
5783 admin2 2026 04:17 AM admin2 2026 04:17 AM 7 Brew 2,024 6.6
5784 admin2 2026 04:17 AM admin2 2026 04:17 AM 7 Brew 2,025 6.6
Tenant Year Cap Rate

Credit (what net-lease buyers care about)

Credit Snapshot

U.S. Renal Care

Cap Rates NNN
Last Year 7.2%
This Year 7.5%
Change 0.3%
S&P Rating CREDIT
Last Year NR
This Year NR
Change No change

U.S. Renal Care Net Lease: Secure, Essential Investment

U.S. Renal Care is a nationally recognized healthcare tenant specializing in dialysis services and kidney disease treatment. This guide reviews U.S. Renal Care cap rates, lease terms, tenant profile, and key due diligence considerations for buyers and sellers.

Investors often target U.S. Renal Care assets for:

  • Stable Healthcare Demand
  • Essential Dialysis Services
  • Long-Term Net Lease Structure
  • Attractive 1031 Exchange Compatibility

U.S. Renal Care properties require careful evaluation of rent escalations, remaining lease term, renewal options, landlord responsibilities, and local healthcare demographics before underwriting an acquisition.

U.S. Renal Care Properties for 1031 Exchange Buyers

U.S. Renal Care NNN properties often trade differently than traditional retail properties because they are purpose-built healthcare facilities. Buyers should carefully evaluate lease structure, remaining lease term, renewal options, landlord responsibilities, tenant performance, and building adaptability to understand long-term risk, financing potential, and investment returns.

U.S. Renal Care Investment Market Statistics

AVERAGE SALE PRICE

$2,950,000

BUILDING SIZE

6,000 – 10,000 SF

AVERAGE NOI

$185,000

LAND

1.00 – 2.00 Acres

$/SF RANGE

$425 – $700

LEASE TERM SHOWN

15 years

U.S. Renal Care Investor Snapshot (Quick Facts)

Origins & Growth (Past)

• Founded in 2000
• Expanded through clinic development and acquisitions
• Built a nationwide dialysis clinic network
• Focused on outpatient kidney care services
• Invested in clinical quality and patient outcomes
• Leading U.S. dialysis care provider

Where U.S. Renal Care Stands Today

• Nationwide dialysis network
• Leading kidney care provider
• High recurring patient visits
• Primarily corporate-operated clinics
• Expanding home dialysis services
• Focus on clinical quality and operational efficiency

Where U.S. Renal Care Stands Today

• Expanded home dialysis
• Increased care efficiency
• Enhanced patient outcomes
• Growing care coordination
• Optimized clinic network
• Focus on kidney care
• Benefiting from healthcare demand

Why investors buy U.S. Renal Care NNN Properties or U.S. Renal Care ground Lease Properties?

Pros (what buyers like)

  • Essential healthcare service
    Dialysis treatment is a life-sustaining medical necessity, creating stable and recurring patient demand regardless of economic conditions.
  • Leading dialysis operator
    U.S. Renal Care is one of the largest dialysis providers in the United States, with hundreds of dialysis centers and home dialysis programs across multiple states.
  • Recession-resistant industry
    Kidney disease treatment is a non-discretionary healthcare service, making dialysis facilities less sensitive to economic downturns than many retail properties.
  • Long-term lease structures
    Many U.S. Renal Care properties are leased on long-term NNN or ground lease agreements, providing predictable income and appealing to passive investors and 1031 exchange buyers.
  • Specialized facility investment
    Dialysis centers require significant infrastructure, medical equipment, and water-treatment systems, which can increase tenant commitment to a location.
  • Growing healthcare demand
    An aging population and increasing prevalence of chronic kidney disease continue to support long-term demand for dialysis services.

Cons (what can bite you)

  • Non-investment-grade tenant
    U.S. Renal Care is a privately held healthcare company, so investors cannot rely on public credit ratings like they can with many publicly traded tenants.
  • Healthcare reimbursement exposure
    Dialysis operators depend heavily on Medicare, Medicaid, and private insurance reimbursement programs, creating exposure to regulatory and reimbursement changes.
  • Limited alternative uses
    Dialysis centers are highly specialized medical facilities that may require substantial renovation costs if the tenant vacates.
  • Lease structure variability
    Some assets may be structured as NN or modified NNN leases, leaving certain maintenance, roof, structure, or capital expenses with the landlord.
  • Location-specific performance
    The long-term value of a dialysis property can depend heavily on local demographics, referral networks, and healthcare demand.
  • Operational consolidation risk
    Healthcare providers periodically evaluate facility performance and may consolidate locations or shift services within a market over time.

Find out more

U.S. Renal Care Background & History

U.S. Renal Care is one of the largest dialysis providers in the United States, specializing in the treatment of chronic kidney disease and end-stage renal disease (ESRD). The company operates a nationwide network of outpatient dialysis centers and home dialysis programs that provide life-sustaining care to patients requiring regular treatment.

Since its founding, U.S. Renal Care has expanded through a combination of new clinic development, partnerships with physicians, and strategic acquisitions. Today, the company serves thousands of patients across multiple states, focusing on high-quality clinical outcomes and patient-centered care.

Unlike many retail or service businesses, dialysis treatment is a medical necessity. Patients typically receive treatment multiple times per week, creating recurring demand that is generally less affected by economic cycles. As a result, dialysis facilities are often viewed as part of the broader healthcare infrastructure that supports local communities.

Why U.S. Renal Care Matters to NNN Investors

U.S. Renal Care operates within the essential healthcare sector, where demand is driven by ongoing patient needs rather than discretionary consumer spending. The company’s facilities serve patients who require regular dialysis treatments, helping create consistent utilization and long-term operational stability.

Many dialysis centers are purpose-built medical facilities with specialized infrastructure, including water treatment systems, backup power capabilities, and treatment stations designed specifically for kidney care. This significant investment in facility improvements can increase tenant commitment to a location.

In addition, demographic trends such as an aging population and the growing prevalence of diabetes and kidney disease continue to support long-term demand for dialysis services. These factors help explain why healthcare-oriented net lease properties often attract investors seeking stable, necessity-based real estate.

What Buyers and Sellers Should Evaluate

For investors evaluating U.S. Renal Care NNN properties, a U.S. Renal Care net lease, or a U.S. Renal Care ground lease, the investment thesis is typically centered on tenant operations, lease structure, and the long-term strength of the underlying healthcare market. As a result, buyers often place greater emphasis on lease economics, patient demographics, and real estate fundamentals than on brand recognition alone.

Common searches include U.S. Renal Care real estate, U.S. Renal Care cap rate, U.S. Renal Care lease term, U.S. Renal Care tenant credit, and dialysis center investments. Ultimately, U.S. Renal Care net lease value is driven by site-specific factors, lease structure, facility performance, and the property’s role within the company’s broader operating network.

As healthcare delivery continues to evolve, the strongest U.S. Renal Care locations tend to be those with established patient bases, favorable demographics, strong referral networks, and limited competitive supply. Buyers and sellers should evaluate each property individually, including lease language, renewal options, landlord responsibilities, local healthcare demand, and long-term market fundamentals.

In addition, investors should consider reimbursement-related risks, facility specialization, tenant commitment to the location, and overall cash-flow durability when assessing acquisition or disposition opportunities.

our team of experts are here for you

Our team helps investors evaluate NNN properties with practical, market-based guidance. In addition, we support buyers and sellers with lease review, pricing analysis, and due diligence strategy.

Whether you are comparing U.S. Renal Care ground lease properties or fee simple U.S. Renal Care assets, we can help you review the details that affect risk and long-term value. As a result, clients can make more confident decisions based on lease structure, location quality, and investment goals.

Scroll to Top